Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) is now available.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced a special cash dividend of HKD 1.5 per share, with shareholders’ approval set for July 21, 2025. This announcement may impact the company’s financial distribution strategy and provide returns to shareholders, reflecting the company’s current financial health and commitment to shareholder value.
The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Hong Kong Stock Exchange and is involved in producing a range of medical products.
Average Trading Volume: 9,690,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.11B
Learn more about 1558 stock on TipRanks’ Stock Analysis page.